| scholarly article | Q13442814 |
| P50 | author | Jingfeng Tang | Q83144785 |
| Cefan Zhou | Q89674143 | ||
| P2093 | author name string | Jing Yang | |
| Yi Zhang | |||
| Xing-Zhen Chen | |||
| Huang Huang | |||
| Hui Xiong | |||
| Hongxia Cheng | |||
| Wenying Qin | |||
| Yefu Wang | |||
| P2860 | cites work | Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex | Q24316055 |
| The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression | Q24316299 | ||
| MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines | Q24601753 | ||
| Old, new and emerging functions of caspases | Q27686885 | ||
| Microtubule-binding agents: a dynamic field of cancer therapeutics | Q27690249 | ||
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Requirement of Pygopus 2 in breast cancer | Q28281881 | ||
| Crystal structure analysis of the PHD domain of the transcription co-activator Pygopus. | Q52679765 | ||
| Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer. | Q53832317 | ||
| Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways | Q57267084 | ||
| The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression | Q57407953 | ||
| Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells | Q72214860 | ||
| Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage | Q73316771 | ||
| Bcl-2 protects against apoptosis-related microtubule alterations in neuronal cells | Q73561365 | ||
| Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade | Q74061459 | ||
| Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer | Q28306764 | ||
| Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp | Q28546603 | ||
| A cytoplasmic inhibitor of the JNK signal transduction pathway | Q28586970 | ||
| Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 | ||
| Hypericins as potential leads for new therapeutics | Q33553257 | ||
| Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy | Q34113542 | ||
| Pygo2 Associates with MLL2 Histone Methyltransferase and GCN5 Histone Acetyltransferase Complexes To Augment Wnt Target Gene Expression and Breast Cancer Stem-Like Cell Expansion | Q34416310 | ||
| Proteomics for studying cancer cells and the development of chemoresistance | Q34447866 | ||
| Hypericin in cancer treatment: more light on the way. | Q34535031 | ||
| Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. | Q34602976 | ||
| Transcriptional regulators of the human multidrug resistance 1 gene: recent views | Q34816232 | ||
| Drugs that target dynamic microtubules: a new molecular perspective | Q35163252 | ||
| Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. | Q35165455 | ||
| The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer. | Q35563862 | ||
| Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy | Q35575328 | ||
| Multi-functional polymeric nanoparticles for tumour-targeted drug delivery | Q36409038 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment. | Q36606033 | ||
| Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13. | Q36638798 | ||
| Pygopus and the Wnt signaling pathway: a diverse set of connections | Q37135610 | ||
| Prognostic significance of PLIN1 expression in human breast cancer. | Q37688087 | ||
| Nanomedicinal strategies to treat multidrug-resistant tumors: current progress | Q37763152 | ||
| Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities | Q38183686 | ||
| Transcription factor c-Jun activation represses mdr-1 gene expression. | Q38351649 | ||
| Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells | Q38848601 | ||
| Pygo2 siRNA Inhibit the Growth and Increase Apoptosis of U251 Cell by Suppressing Histone H3K4 Trimethylation | Q38887767 | ||
| Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma. | Q38933927 | ||
| Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel. | Q39288934 | ||
| The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat. | Q39709166 | ||
| PHF8 targets histone methylation and RNA polymerase II to activate transcription. | Q39710578 | ||
| Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase | Q40333053 | ||
| Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs | Q40386853 | ||
| Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding | Q40556790 | ||
| Novel role for JNK as a stress-activated Bcl2 kinase | Q40809860 | ||
| Suppression of anti-microtubule agent-induced apoptosis by nitric oxide: possible mechanism of a new drug resistance | Q41050392 | ||
| Bcl-2 phosphorylation required for anti-apoptosis function | Q41111068 | ||
| Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. | Q42110512 | ||
| The role of Pygopus 2 in rat glioma cell growth | Q44669927 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 27915-27928 | |
| P577 | publication date | 2017-03-02 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells | |
| P478 | volume | 8 |
| Q49746746 | 20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway |
| Q98163537 | LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes |
| Q60921650 | N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling |
Search more.